Halpern Financial’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-500
Closed -$6.79K 228
2024
Q1
$6.79K Hold
500
﹤0.01% 175
2023
Q4
$5.08K Hold
500
﹤0.01% 201
2023
Q3
$4.57K Hold
500
﹤0.01% 186
2023
Q2
$3.63K Hold
500
﹤0.01% 229
2023
Q1
$4.23K Hold
500
﹤0.01% 156
2022
Q4
$3.75K Hold
500
﹤0.01% 162
2022
Q3
$4.03K Hold
500
﹤0.01% 172
2022
Q2
$5.8K Hold
500
﹤0.01% 192
2022
Q1
$5.61K Hold
500
﹤0.01% 186
2021
Q4
$3.25K Hold
500
﹤0.01% 216
2021
Q3
$3.81K Hold
500
﹤0.01% 222
2021
Q2
$6.33K Hold
500
﹤0.01% 171
2021
Q1
$6.5K Sell
500
-350
-41% -$3.23K ﹤0.01% 164
2020
Q4
$2.86K Hold
850
﹤0.01% 173
2020
Q3
$3.32K Hold
850
﹤0.01% 171
2020
Q2
$4.5K Hold
850
﹤0.01% 134
2020
Q1
$3.53K Hold
850
﹤0.01% 133
2019
Q4
$10.3K Buy
+850
New +$12K 0.01% 122

Other funds holding EOLS

Halpern Financial's EOLS Position: Q2 2024 in Review

Halpern Financial sold out of Evolus (EOLS) in Q2 2024, closing a stake of 500 shares — an estimated $6.79K sold.

Halpern Financial first reported a position in EOLS in Q4 2019 and held it in 18 quarters. The position peaked at $10.3K in Q4 2019. 156 funds tracked by Wall St. Rank hold EOLS as of Q2 2024.

  • Halpern Financial reported no remaining Evolus position as of Q2 2024 after selling out during the quarter.
  • Halpern Financial sold 500 Evolus shares in Q2 2024, an estimated $6.79K.
  • Halpern Financial first reported a position in Evolus in Q4 2019 and held it in 18 quarters.
  • Halpern Financial's Evolus position peaked at $10.3K in Q4 2019.
  • 156 funds tracked by Wall St. Rank held Evolus as of Q2 2024.

Based on Halpern Financial's 13F filing for Q2 2024, filed 9 Jul 2024.